NCT Number: NCT00194948
Treatment Choices for Improving Adherence and Outcome
This study will determine the effectiveness of offering primary care patients their preferred treatment versus one that is less desirable in improving treatment adherence and outcome.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Cornell Internal Medicine Associates, New York, United States
About this study
This study investigates whether offering primary care patients treatment that is congruent with their preferred first choice improves adherence and outcomes, in comparison to offering treatment that is not congruent with their preferred first choice. All subjects are offered a treatment with demonstrated efficacy, namely either the antidepressant medication escitalopram or Interpersonal Psychotherapy for 5 months. We hypothesize that patients who receive congruent treatment will be more likely to initiate treatment, adhere to treatment, and achieve depression remission.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age 21-99
- English-speaking
- DSM-IV criteria for major depression
Exclusion criteria
- unable to give informed consent
- MMSE<24
- DSM-IV diagnosis of bipolar disorder, psychotic disorder, current alcohol or substance abuse
- active suicide ideation
- aphasia
- acute or severe medical illness
- currently receiving either antidepressant medication or psychotherapy
Treatment and study plan
interpersonal psychotherapy
BehavioralPrimary outcomes
-
treatment initiation
-
treatment adherence
Secondary outcomes
-
depressive symptomatology
Sponsors and collaborators
Lead sponsor
Weill Medical College of Cornell University
Other
Collaborators
- National Institute of Mental Health (NIMH)
Registry information
Official study title
Patient Preference in Primary Care Depression Treatment
Important dates
- Study start
- 2003
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Sep 19, 2005
- Registry last updated
- Nov 4, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Neuroimaging Sleep and Mood in Depression
NCT05497414
Depressive Disorder, Depressive Disorder, Major
Boston, Massachusetts, United States
View Trial DetailsClinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints
NCT05257902
Depressive Disorder, Depressive Disorder, Major
Seoul, Irwon-dong, Gangnam-gu, South Korea
View Trial DetailsDepression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
NCT01962753
Depressive Disorder, Depressive Disorder, Major
Besançon, France
View Trial DetailsThe Brain-Heart-Gut Connection
NCT06748274
Autonomous Dysfunction, Behavior
Bern, Canton of Bern, Switzerland
View Trial Details